Home/Filings/4/0001562180-22-007464
4//SEC Filing

Colvin Richard A 4

Accession 0001562180-22-007464

CIK 0001293971other

Filed

Nov 2, 8:00 PM ET

Accepted

Nov 3, 4:19 PM ET

Size

11.0 KB

Accession

0001562180-22-007464

Insider Transaction Report

Form 4
Period: 2022-11-01
Colvin Richard A
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-11-01+30,00075,006 total
  • Award

    Stock Options (Right to buy)

    2022-11-01+60,00060,000 total
    Exercise: $6.35Exp: 2032-11-01Common Stock (60,000 underlying)
Footnotes (2)
  • [F1]Restricted stock unit awards vest over a four-year period at the rate of 25% on 11/1/2023, 25% on 11/1/2024, 25% on 11/1/2025, and 25% on 11/1/2026.
  • [F2]The stock option vests over a four-year period at the rate of 25% on 11/1/2023 and then in 36 equal monthly installments thereafter.

Issuer

bluebird bio, Inc.

CIK 0001293971

Entity typeother

Related Parties

1
  • filerCIK 0001944069

Filing Metadata

Form type
4
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 4:19 PM ET
Size
11.0 KB